Challenges of early detection of renal cell carcinoma
The incidence of kidney cancer in the UK has risen [...]
Ilixadencel granted Regenerative Medicine Advanced Therapy by FDA for metastatic kidney cancer
The US Food and Drug Administration (FDA) has designated ilixadencel [...]
Phase 1 trial of vorolanib plus everolimus for advanced kidney cancer
A new combination of vorolanib, a tyrosine kinase inhibitor plus [...]
Impact of lymph-node positive kidney cancer on survival
A recent study published in the journal Cancer last month [...]
Patient-reported outcomes with atezolizumab plus bevacizumab in metastatic kidney cancer
This study describes patient-reported outcomes from the phase 3 IMmotion151 [...]
Targeted therapy dose reduction resulted in better clinical outcomes
A recent post hoc analysis of the results from the [...]
Atezolizumab alone or in combination with bevacizumab for untreated metastatic kidney cancer
This paper reports patient-reported outcomes from the phase 2 IMmotion150 [...]
Cryoablation is safe and effective for small kidney tumours
A new study published in the American Journal of Roentgenology [...]
Positive results from trial of cabozantinib plus nivolumab combination in untreated metastatic kidney cancer
Results from the pivotal phase 3 CheckMate-9ER clinical trial evaluating [...]
Cabozantinib in combination with immunotherapy for advanced kidney cancer
In this video interview, Dr Monty Pal from the City [...]
